Garuda Therapeutics News and Activities

Acquisition, funding and merger involving Garuda Therapeutics.

• The new name of Garuda Therapeutics is Stratus Therapeutics. (posted on May 12 2025).

View the org chart displaying its 23 main executives

Most searched biographies at Garuda Therapeutics

• Avanish Vellanki, President and Chief Executive Officer and Direct...
• Adam Craig, Independent Director
• Laurence Reid, Director

Popular executive movements at Garuda Therapeutics

• Jay Sorensen has joined the company as Vice President, Manufacturing, Facilities and Validation  (posted on May 12 2025).
• Avanish Vellanki has joined the company as President and Chief Executive Officer and Director  (posted on March 4 2025).
• Adam Craig who was Interim Chief Executive Officer, becomes Independent Director  (posted on March 4 2025).

Create your alert
to follow the executive moves at Garuda Therapeutics.

Garuda Therapeutics has 2,353 competitors including Incyte (United States (USA)), Anthos Therapeutics (United States (USA)) and Valneva (France).

Popular M&A news in Biotechnology

• Renasant Bio has just announced a $54 Million fundraising (posted on July 15 2025).
• Illimis Therapeutics has just announced a $42 Million fundraising (posted on July 14 2025).
• Nuclidium has just announced a $99 Million fundraising (posted on July 14 2025).

Popular contacts in Biotechnology

• Jasbir Seehra - Chief Executive Officer and Chairman of the Board at Keros Therapeutics
• Andrea Jackson - Director at Ultivue
• Sandra Smith - Senior Vice President, Clinical Solutions & Strategic Partnerships at WIRB-Copernicus Group

Learn more about the Biotechnology industry

Press releases by Garuda Therapeutics

• Stratus Therapeutics Strengthens Executive Team with Appointment of Michael P. Cooke, PhD, as Chief Scientific Officer - Stratus
• Stratus Announces Publication of Stratus PRIME™ HSC Platform in the American Journal of Hematology - Stratus
• Stratus Therapeutics | On-Demand Blood Stem Cell Therapies
• Garuda Therapeutics Announces Name Change to Stratus Therapeutics to Reflect Mission of Pioneering Full Hematopoietic System Renewal - Stratus
• Garuda Therapeutics Announces the Appointment of Avanish Vellanki as President and Chief Executive Officer - Stratus
• Garuda Therapeutics Closes $50 Million Series A-1 Financing to Advance Off-the-Shelf Blood Stem Cell Therapies - Stratus
• Garuda Therapeutics Announces the Appointment of Avanish Vellanki as President and Chief Executive Officer
• Garuda Therapeutics Closes $50 Million Series A-1 Financing to Advance Off-the-Shelf Blood Stem Cell Therapies
• Garuda Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
• Garuda Therapeutics Named “Overall Cell Biology Company of the Year” By BioTech Breakthrough
• View more press releases Close

Social media about Garuda Therapeutics

• Garuda Therapeutics on Wikipedia, Google News & Yahoo Finance
• Garuda Therapeutics on LinkedIn, Twitter & YouTube